Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease

Patients with chronic kidney disease (CKD) are at higher risk for severe coronavirus disease 2019 (COVID-19). Such patients are more likely to develop “COVID-19-induced acute kidney injury (AKI)”, which exacerbates the pre-existing CKD and increases the mortality rate of the patients. COVID-19-induc...

Descripción completa

Detalles Bibliográficos
Autor principal: Kazama, Itsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308890/
https://www.ncbi.nlm.nih.gov/pubmed/35871404
http://dx.doi.org/10.1007/s00011-022-01619-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308890/
https://www.ncbi.nlm.nih.gov/pubmed/35871404
http://dx.doi.org/10.1007/s00011-022-01619-6

Ejemplares similares